Sunday 11 October 2026
Export all ITRI data to Excel Powerpack
Itron, Inc.
ITRI Technology Scientific & Technical Instruments
Itron, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, down 3.02% from fiscal 2024. In the quarter to June 2026, revenue fell 7.23%, EPS fell 19.3%, free cash flow fell 10.1% and total debt rose 26.5%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
85.58
1.35
+1.60%
Follow ITRI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
22.01 | 14.03 | 14.05 | 14.21 |
P/S ratio |
2.37 | 1.78 | 1.71 | 1.66 | |
P/FCF ratio |
16.67 | 11.03 | 10.16 | 9.90 | |
P/Operating CF |
48.36 | 35.40 | 46.89 | 43.31 | |
P/B ratio |
3.33 | 2.43 | 2.46 | 2.33 | |
Price to Tangible BV |
9.57 | 13.63 | 0.00 | 0.00 | |
EV/Sales |
2.33 | 1.88 | 2.27 | 2.22 | |
EV/EBITDA |
15.77 | 12.04 | 14.50 | 13.65 | |
EV/Operating CF |
15.32 | 10.97 | 12.71 | 12.43 | |
EV/FCF |
16.43 | 11.62 | 13.51 | 13.25 | |
Quick Ratio |
1.72 | 1.37 | 1.93 | 1.94 | |
Current Ratio |
2.17 | 1.80 | 2.66 | 2.75 | |
Net Debt/EBITDA |
(0.89) | 2.43 | 9.79 | 8.59 | |
Debt/Assets |
33.60% | 33.55% | 39.56% | 39.44% | |
Debt/Equity |
0.73 | 0.72 | 0.97 | 0.96 | |
Asset Turnover |
0.68 | 0.66 | 0.63 | 0.60 | |
Operating CF/Net income |
1.80 | 1.17 | 1.60 | 1.65 | |
Capex/Depreciation |
(0.32) | (0.52) | (0.32) | (0.32) | |
Interest Coverage |
14.48 | 14.14 | 11.63 | 13.19 | |
Research and Development Expense of Revenue |
8.60% | 9.29% | 9.37% | 9.97% | |
Selling, General and Administrative Expense of Revenue |
14.29% | 16.67% | 17.95% | 15.94% | |
Intangible Assets out of Total Assets |
0.30 | 0.38 | 0.50 | 0.49 | |
Share Based Compensation of Revenue |
2.48% | 2.56% | 3.42% | 2.18% | |
Graham Net Nets |
0.03 | (0.04) | (0.21) | (0.21) | |
Graham Number |
69.06 | 75.44 | 72.30 | 71.35 | |
Earnings Yield |
4.54% | 7.13% | 7.12% | 7.04% | |
Free Cash Flow Yield |
6.00% | 9.07% | 9.84% | 10.10% | |
Revenue per Share |
12.71 | 12.57 | 13.12 | 12.77 | |
Operating CF per Share |
2.58 | 2.62 | 1.91 | 2.00 | |
Capex per Share |
(0.10) | (0.17) | (0.15) | (0.15) | |
Free Cash Flow per Share |
2.48 | 2.45 | 1.77 | 1.85 | |
Cash per Share |
29.12 | 22.43 | 15.94 | 16.90 | |
Shareholders Equity per Share |
37.46 | 38.21 | 36.41 | 37.15 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
37.46 | 38.21 | 36.41 | 37.15 | |
Free Cash Flow |
113.41 | 111.51 | 78.97 | 81.49 | |
Working Capital |
1,156.66 | 810.09 | 951.06 | 985.30 | |
Capital Expenditures |
(4.42) | (7.81) | (6.53) | (6.60) | |
Net Current Asset Value |
146.69 | (160.19) | (824.57) | (805.90) | |
EV/EBIT |
18.89 | 14.22 | 17.51 | 16.79 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
19.18 | 13.49 | 13.17 | 12.55 | |
| Other line items | |||||
Average Receivables |
354.14 | 359.13 | 369.88 | 345.72 | |
Average Payables |
148.92 | 150.61 | 168.67 | 134.93 | |
Average Inventory |
265.95 | 256.81 | 260.89 | 271.01 | |
Average Assets |
3,538.09 | 3,564.17 | 3,740.67 | 3,808.66 | |
Average Common Equity |
1,541.05 | 1,574.81 | 1,569.01 | 1,636.28 |
Columns are period end dates